CEACAM1 and type 2 diabetes mellitus: In our previous study, we revealed that there were no significant differences in Galectin-9 and CD66a/c/d/e expression in T cells, monocytes, dendritic cells, and NKT-like cells from T2DM patients compared to healthy volunteers 18.